The carcinogen safrole increases intracellular free Ca2+ levels and causes death in MDCK cells

Chin J Physiol. 2007 Feb 28;50(1):34-40.

Abstract

The effect of the carcinogen safrole on intracellular Ca2+ movement in renal tubular cells has not been explored previously. The present study examined whether safrole could alter Ca2+ handling in Madin-Darby canine kidney (MDCK) cells. Cytosolic free Ca2+ levels ([Ca2+]i) in populations of cells were measured using fura-2 as a fluorescent Ca2+ probe. Safrole at concentrations above 33 microM increased [Ca2+]i in a concentration-dependent manner with an EC50 value of 400 microM. The Ca2+ signal was reduced by 90% by removing extracellular Ca2+, but was not affected by nifedipine, verapamil, or diltiazem. Addition of Ca2+ after safrole had depleted intracellular Ca(2+)-induced dramatic Ca2+ influx, suggesting that safrole caused store-operated Ca2+ entry. In Ca(2+)-free medium, after pretreatment with 650 microM safrole, 1 microM thapsigargin (an endoplasmic reticulum Ca2+ pump inhibitor) failed to release more Ca 2+. Inhibition of phospholipase C with 2 microM U73122 did not affect safrole-induced Ca2+ release. Trypan blue exclusion assays revealed that incubation with 650 microM safrole for 30 min did not kill cells, but killed 70% of cells after incubation for 60 min. Collectively, the data suggest that in MDCK cells, safrole induced a [Ca2+] increase by causing Ca2+ release from the endoplasmic reticulum in a phospholipase C-independent fashion, and by inducing Ca2+ influx via store-operated Ca2+ entry. Furthermore, safrole can cause acute toxicity to MDCK cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium / metabolism*
  • Calcium / pharmacology
  • Calcium Channel Blockers / pharmacology
  • Carcinogens / pharmacology*
  • Cell Line
  • Cell Survival / drug effects
  • Culture Media / chemistry
  • Cytosol / metabolism
  • Dogs
  • Endoplasmic Reticulum / metabolism
  • Estrenes / pharmacology
  • Extracellular Fluid / metabolism
  • Intracellular Membranes / metabolism*
  • Kidney / drug effects*
  • Kidney / metabolism
  • Kidney / physiology*
  • Osmolar Concentration
  • Phosphodiesterase Inhibitors / pharmacology
  • Pyrrolidinones / pharmacology
  • Safrole / pharmacology*
  • Thapsigargin / pharmacology
  • Type C Phospholipases / antagonists & inhibitors

Substances

  • Calcium Channel Blockers
  • Carcinogens
  • Culture Media
  • Estrenes
  • Phosphodiesterase Inhibitors
  • Pyrrolidinones
  • 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione
  • Thapsigargin
  • Type C Phospholipases
  • Safrole
  • Calcium